Model | Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
variable | β | t | p Value | β | t | p Value | β | t | p Value | β | t | p Value | β | t | p Value |
Self-efficacy | −0.616 | −7.945 | <0.001 | −0.518 | −7.502 | <0.001 | −0.496 | −7.385 | <0.001 | −0.413 | −5.356 | <0.001 | −0.410 | −5.387 | <0.001 |
Adherence | −0.412 | −5.964 | <0.001 | −0.417 | −6.231 | <0.001 | −0.408 | −5.940 | <0.001 | −0.349 | −4.888 | <0.001 | |||
Demographics | |||||||||||||||
Age | −0.181 | −2.719 | 0.008 | −0.196 | −2.906 | 0.005 | −0.201 | −2.783 | 0.003 | ||||||
Education | −0.258 | −2.304 | 0.023 | −0.239 | −2.111 | 0.038 | −0.273 | −2.447 | 0.015 | ||||||
Lifestyle | |||||||||||||||
Primary care | 0.184 | 2.468 | 0.015 | 0.147 | 2.166 | 0.045 | |||||||||
Employee status | −0.113 | −1.514 | 0.134 | −0.054 | −1.291 | 0.467 | |||||||||
Tobacco use | −0.023 | −0.295 | 0.769 | −0.017 | −0.120 | 0.826 | |||||||||
Disease characteristics | |||||||||||||||
Adverse | 0.064 | 0.988 | 0.356 | ||||||||||||
Coexisting disease | 0.139 | 0.735 | 0.054 | ||||||||||||
Systolic pressure | 0.139 | 2.092 | 0.045 | ||||||||||||
R2 | 0.380 | 0.540 | 0.589 | 0.641 | 0.674 | ||||||||||
F | 63.124 | 59.937 | 23.399 | 11.457 | 10.599 | ||||||||||
p | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||||
ΔR2 | 0.380 | 0.160 | 0.049 | 0.052 | 0.034 | ||||||||||
ΔF | 63.124 | 35.567 | 2.899 | 1.616 | 3.13 | ||||||||||
Mediation effects | |||||||||||||||
Indirect value | 18.5 | 8.3 | 10.8 | 3.2 | |||||||||||
95%CI | −0.0472 to −0.0115 | −0.0255 to 0.0021 | −0.0297 to 0.0100 | −0.0546 to 0.0577 | |||||||||||
Δp | <0.001 | <0.001 | 0.026 | 0.131 | 0.034 |